๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest

Pharma Glossary

The definitive, structured ontology of pharmaceutical, biotechnology, and medical device acronyms, regulations, and terminology.

All Terms Biotechnology Clinical Trials Manufacturing Pharmacovigilance Quality Assurance Regulatory Affairs
A B C D E F G H I L M N O P Q R S T U V W
A
ADR Pharmacovigilance
Adverse Drug Reaction.
Local Context (Ireland/EU): A response to a medicinal product which is noxious and unintended, where a causal relationship between product and event is suspected.
AE Pharmacovigilance
Adverse Event.
Local Context (Ireland/EU): Any untoward medical occurrence in a patient or subject administered a drug. Reports are managed in the EU via EudraVigilance.
ALCOA+ Quality Assurance
Data Integrity guidelines specifying that records must be Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available.
Local Context (Ireland/EU): Regulatory agencies like the HPRA place massive audit focus on ALCOA+ compliance to ensure patient safety and product quality.
Annex 1 Regulatory Affairs
The section of the EU Good Manufacturing Practice (GMP) guidelines governing the manufacture of sterile medicinal products.
Local Context (Ireland/EU): A major revision of Annex 1 came into operation in August 2023, introducing stricter requirements for contamination control strategy (CCS).
ASMF Regulatory Affairs
Active Substance Master File.
Local Context (Ireland/EU): A submission to regulatory authorities providing confidential detailed information about the manufacture and control of an active substance (API).
ATMP Biotechnology
Advanced Therapy Medicinal Product.
Local Context (Ireland/EU): Medicinal products based on gene therapy, somatic cell therapy, or tissue engineering. Evaluated centrally by the EMA Committee for Advanced Therapies (CAT).
Audit Trail Quality Assurance
A secure, computer-generated, time-stamped electronic record that allows for the reconstruction of the course of events relating to data entry or modification.
Local Context (Ireland/EU): Mandatory under EU GMP Annex 11 (Computerised Systems) to ensure data transparency.
B
Benefit-Risk Balance Pharmacovigilance
The relationship between the positive therapeutic effects of a product compared to its risks (safety issues).
Local Context (Ireland/EU): Regulators continuous evaluate this balance; a negative shift can lead to drug suspension or withdrawal.
Bioprocess Operator Biotechnology
A technical specialist responsible for monitoring bioreactors, filtration systems, and cleanroom biomanufacturing lines.
Local Context (Ireland/EU): One of the most in-demand vocational roles in Ireland's biopharma hubs.
Bioreactor Manufacturing
An engineered vessel or device that supports a biologically active environment for growing cells or organisms.
Local Context (Ireland/EU): Biologics hubs in Ireland (like Pfizer Grange Castle and Eli Lilly Limerick) utilize massive bioreactors for antibody production.
Biosimilar Biotechnology
A biological medicine highly similar to another already approved biological medicine (the reference product).
Local Context (Ireland/EU): Regulated in Europe via strict comparative clinical and quality testing to establish therapeutic equivalence.
C
Calibration Quality Assurance
The demonstration that a particular instrument or device produces results within specified limits by comparison with those produced by a standard.
Local Context (Ireland/EU): Calibration schedules must be strictly maintained and logged to avoid quality deviations.
CAPA Quality Assurance
Corrective and Preventive Action.
Local Context (Ireland/EU): A system used to investigate, root cause, and eliminate the recurrence of quality issues. Mandatory under EU GMP Chapter 1.
CAR-T Therapy Biotechnology
Chimeric Antigen Receptor T-cell therapy. A type of immunotherapy where a patient's T cells are genetically engineered to target cancer cells.
Local Context (Ireland/EU): Classified as an ATMP in the EU, requiring complex vein-to-vein logistical tracking and specialized hospital validation.
Cell Bank Biotechnology
A collection of ampoules containing a single pool of cells of uniform composition, stored under deep freeze conditions.
Local Context (Ireland/EU): Divided into Master Cell Bank (MCB) and Working Cell Bank (WCB) to ensure consistent cell culture starting materials.
CEP Regulatory Affairs
Certificate of Suitability.
Local Context (Ireland/EU): A certificate issued by the EDQM confirming that a substance complies with the monographs of the European Pharmacopoeia.
cGMP Manufacturing
Current Good Manufacturing Practice.
Local Context (Ireland/EU): Regulations enforcing proper design, monitoring, and control of manufacturing facilities and processes. Audited directly by the HPRA.
Change Control Quality Assurance
A formal quality management system designed to propose, evaluate, review, and execute changes in equipment, processes, or materials.
Local Context (Ireland/EU): Required to prevent unauthorized modifications that could compromise the validated status of a manufacturing line.
CHO Cells Biotechnology
Chinese Hamster Ovary cells.
Local Context (Ireland/EU): The mammalian cell line most commonly used in industrial biomanufacturing to produce recombinant therapeutic proteins.
CIOMS Pharmacovigilance
Council for International Organizations of Medical Sciences.
Local Context (Ireland/EU): An international body that publishes consensus guidelines for drug safety reporting formats (e.g., CIOMS I forms).
CIP Manufacturing
Clean-in-Place.
Local Context (Ireland/EU): An automated method of cleaning the interior surfaces of pipes, vessels, process equipment, and filters without disassembly.
CRA Clinical Trials
Clinical Research Associate (Monitor).
Local Context (Ireland/EU): The professional responsible for monitoring trial sites to ensure compliance with the protocol, GCP guidelines, and regulatory requirements.
CRF Clinical Trials
Case Report Form.
Local Context (Ireland/EU): A printed, optical, or electronic document designed to record all of the protocol-required information on each trial subject.
CRISPR Biotechnology
Clustered Regularly Interspaced Short Palindromic Repeats. A gene-editing technology allowing precise edits to genomic sequences.
Local Context (Ireland/EU): Used extensively in biotechnology R&D hubs in Dublin and Cork to research disease models.
CRO Clinical Trials
Contract Research Organisation.
Local Context (Ireland/EU): A company providing support services to the pharmaceutical and biotech industries, managing clinical trials on behalf of sponsors.
CTA Regulatory Affairs
Clinical Trial Application.
Local Context (Ireland/EU): The formal application requesting approval to conduct a clinical trial in the EU, now submitted via the Clinical Trials Information System (CTIS).
CTD Regulatory Affairs
Common Technical Document.
Local Context (Ireland/EU): The internationally agreed format for organizing applications (Modules 1-5) submitted to regulatory authorities.
CTIS Clinical Trials
Clinical Trials Information System.
Local Context (Ireland/EU): The single-entry portal managed by the EMA for submitting and evaluating clinical trials within the EU/EEA.
CTR Clinical Trials
Clinical Trials Regulation (EU No 536/2014).
Local Context (Ireland/EU): The harmonized EU regulation that entered into force in 2022, streamlining clinical trial approvals across the entire European Union.
D
Deviation Quality Assurance
An unplanned departure from an approved instruction, SOP, specification, or validation protocol during manufacturing or testing.
Local Context (Ireland/EU): All deviations must be documented, risk-assessed, and signed off by the Quality Unit before batch release.
Double-Blind Clinical Trials
A trial design where neither the subjects nor the investigators/medical staff know which treatment group patients are assigned to.
Local Context (Ireland/EU): Minimizes bias in reporting and clinical evaluation.
Downstream Processing Manufacturing
The purification and recovery of product from cell culture fluid or biological harvests.
Local Context (Ireland/EU): Utilizes filtration, chromatography, and viral inactivation steps to isolate pure proteins.
DSUR Pharmacovigilance
Development Safety Update Report.
Local Context (Ireland/EU): The safety report submitted annually by sponsors during the clinical trial/development phase of an investigational drug.
E
E-E-A-T Quality Assurance
Experience, Expertise, Authoritativeness, and Trustworthiness. Google's core search quality evaluation framework.
Local Context (Ireland/EU): Crucial ranking signal for life science publications in Ireland aiming to rank on Google search for medical and regulatory guidance.
eCTD Regulatory Affairs
Electronic Common Technical Document.
Local Context (Ireland/EU): The electronic version of the CTD format, mandatory for all EMA submissions and most national submissions in Europe.
ELISA Biotechnology
Enzyme-Linked Immunosorbent Assay. An analytical biochemistry assay that uses a solid-phase enzyme immunoassay to detect the presence of a ligand.
Local Context (Ireland/EU): Frequently used by Quality Control labs in Ireland for checking antibody concentration and purity.
EMA Regulatory Affairs
European Medicines Agency.
Local Context (Ireland/EU): The EU body responsible for the scientific evaluation, supervision, and safety monitoring of medicines. Relocated from London to Amsterdam in 2019.
Embargo Regulatory Affairs
A request or agreement that information provided in a press release should not be published by the media until a designated date and time.
Local Context (Ireland/EU): Commonly used when distributing clinical trial phase results or regulatory approval announcements in advance to trusted journalists.
EudraVigilance Pharmacovigilance
The central European database managed by the EMA to collect and monitor suspected adverse reactions to medicines.
Local Context (Ireland/EU): All marketing authorization holders in Ireland must integrate their safety databases with EudraVigilance.
Expression System Biotechnology
The combination of an expression vector and its host cell used to produce a target recombinant protein.
Local Context (Ireland/EU): Includes mammalian (CHO), bacterial (E. coli), and yeast (S. cerevisiae) systems.
F
FDA Regulatory Affairs
Food and Drug Administration (United States).
Local Context (Ireland/EU): The US federal agency regulating food, drugs, and medical devices. HPRA-regulated Irish manufacturing sites exporting to the US are regularly audited by the FDA.
G
GAMP 5 Quality Assurance
Good Automated Manufacturing Practice version 5. A risk-based approach to compliant GxP computerized systems.
Local Context (Ireland/EU): The global standard used by QA departments in Ireland to validate software and automated systems.
GCP Clinical Trials
Good Clinical Practice.
Local Context (Ireland/EU): An international ethical and quality standard for designing, conducting, and reporting clinical trials involving human subjects.
GLP-1 Biotechnology
Glucagon-like peptide-1 receptor agonists. A class of biological drugs used to treat type 2 diabetes and obesity.
Local Context (Ireland/EU): Major manufacturing plants in Ireland are expanding lines to support high global demands for these peptides.
Grade A Manufacturing
The high-risk cleanroom grade for aseptic operations, requiring laminar flow and near-zero particle counts.
Local Context (Ireland/EU): Regulated under EU GMP Annex 1, requiring active microbial and physical monitoring during all filling processes.
Grade B Manufacturing
The background environment cleanroom grade for Grade A zones in aseptic preparation and filling.
Local Context (Ireland/EU): Requires strict personnel gowning and gown validation before entering.
Grade C Manufacturing
Cleanroom grade used for less critical stages of manufacturing, such as preparation of solutions to be filtered.
Local Context (Ireland/EU): Requires controlled access and cleanroom clothing standards.
Grade D Manufacturing
Cleanroom grade used for handling less critical materials and equipment cleaning operations.
Local Context (Ireland/EU): Acts as the entry barrier cleanroom classification in most Irish biopharma plants.
H
Host Cell Proteins Biotechnology
Proteins produced by the host cell line during recombinant protein expression that must be purified out of the final product.
Local Context (Ireland/EU): Monitored as critical process impurities under EU pharmacopoeia specifications.
HPRA Regulatory Affairs
Health Products Regulatory Authority.
Local Context (Ireland/EU): The state agency responsible for regulating medicines, medical devices, and other health products in Ireland. Formerly known as the Irish Medicines Board (IMB).
HVAC Manufacturing
Heating, Ventilation, and Air Conditioning.
Local Context (Ireland/EU): Cleanroom air handling systems that control temperature, humidity, and particle counts, using HEPA filters to prevent product contamination.
I
ICF Clinical Trials
Informed Consent Form.
Local Context (Ireland/EU): The documentation demonstrating that a subject has voluntarily confirmed their willingness to participate in a trial after being fully informed.
ICH Regulatory Affairs
International Council for Harmonisation.
Local Context (Ireland/EU): The global body bringing together regulators and industry to standardize technical requirements for pharmaceutical development (e.g., Q8, Q9, Q10).
ICSR Pharmacovigilance
Individual Case Safety Report.
Local Context (Ireland/EU): The standard electronic format used to report a single suspected adverse reaction case associated with a medicine.
IMP Regulatory Affairs
Investigational Medicinal Product.
Local Context (Ireland/EU): An active ingredient or placebo being tested or used as a reference in a clinical trial. IMPs must be manufactured under strict EU GMP Volume 4 requirements.
Investigator Brochure Clinical Trials
The comprehensive compilation of clinical and non-clinical data on the investigational products under study.
Local Context (Ireland/EU): Must be updated annually by the sponsor and provided to principal investigators.
L
LIMS Quality Assurance
Laboratory Information Management System.
Local Context (Ireland/EU): Software-based laboratory system that manages sample tracking, test results, instrument integration, and regulatory reporting.
LSO Pharmacovigilance
Local Safety Officer.
Local Context (Ireland/EU): The designated pharmacovigilance contact in a specific country, responsible for national reporting and communication with the local regulator (HPRA).
Lyophilisation Manufacturing
Freeze-drying. A low-temperature dehydration process that involves freezing the product, lowering pressure, then removing ice by sublimation.
Local Context (Ireland/EU): Highly utilized in Ireland for packaging and stabilizing delicate protein and biologic therapies.
M
MAA Regulatory Affairs
Marketing Authorization Application.
Local Context (Ireland/EU): The application submitted to the EMA or national authorities (like the HPRA) to market a drug within the European Economic Area (EEA).
MedDRA Pharmacovigilance
Medical Dictionary for Regulatory Activities.
Local Context (Ireland/EU): The global standard medical terminology used to classify adverse event reports and medical diagnoses.
Media Fill Manufacturing
A process simulation test where a sterile microbiological growth medium is run through the manufacturing line to validate aseptic status.
Local Context (Ireland/EU): An essential operational requirement audited strictly by HPRA inspectors to verify cleanroom sterility.
Media Relations Regulatory Affairs
The process of coordinating and building relationships with journalists, editors, and industry publications to secure organic media coverage.
Local Context (Ireland/EU): Irish biotechs build media relations with trade publications like FierceBiotech and regional platforms like Priya Life Science to attract venture capital.
Monoclonal Antibody Biotechnology
Monoclonal Antibody (mAb). Laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system.
Local Context (Ireland/EU): Form the cornerstone of biopharmaceutical manufacturing in Ireland, representing blockbuster treatments like pembrolizumab or adalimumab.
mRNA Vaccine Biotechnology
A vaccine using messenger RNA to instruct cells to produce a protein that triggers an immune response.
Local Context (Ireland/EU): Revolutionized drug delivery during the pandemic, leading to significant investment in lipid nanoparticle (LNP) tech in Ireland.
N
NREC Clinical Trials
National Research Ethics Committees of Ireland.
Local Context (Ireland/EU): The consolidated Irish ethics review body providing single national ethical opinions for clinical trials and medical devices.
O
OOS Quality Assurance
Out of Specification.
Local Context (Ireland/EU): Test results that fall outside the specifications or acceptance criteria established in drug applications or official pharmacopoeias.
OOT Quality Assurance
Out of Trend.
Local Context (Ireland/EU): A stability or release test result that is within the specification limit but is an atypical outlier compared to previous historical batch data.
Orphan Drug Regulatory Affairs
A medicine developed to treat rare medical conditions that would not be profitable to produce without government assistance or market exclusivity.
Local Context (Ireland/EU): In the EU, orphan designation grants 10 years of market exclusivity upon approval to encourage rare disease R&D.
P
PAES Pharmacovigilance
Post-Authorisation Efficacy Study.
Local Context (Ireland/EU): A clinical trial required to address efficacy questions that could not be resolved before marketing authorization.
PASS Pharmacovigilance
Post-Authorisation Safety Study.
Local Context (Ireland/EU): A study carried out after a medicine is authorized to identify, characterize, or quantify a safety hazard or evaluate risk management effectiveness.
PAT Manufacturing
Process Analytical Technology.
Local Context (Ireland/EU): A system for designing, analyzing, and controlling manufacturing through timely measurements of critical quality and performance attributes.
Phase I Clinical Trials
First-in-human clinical testing, typically performed in a small cohort of healthy volunteers (20-100) to evaluate safety and tolerability.
Local Context (Ireland/EU): LSO and REC approval is mandatory prior to recruitment.
Phase II Clinical Trials
Therapeutic exploratory testing in a cohort of patient volunteers (100-500) to assess efficacy, dosing ranges, and safety.
Local Context (Ireland/EU): Conducted across major teaching hospitals in Ireland under principal investigators.
Phase III Clinical Trials
Therapeutic confirmatory testing in large, diverse patient populations (1,000-5,000) to confirm clinical efficacy and monitor adverse reactions.
Local Context (Ireland/EU): Data from Phase III forms the bulk of the marketing authorization application (MAA).
Phase IV Clinical Trials
Post-marketing surveillance studies conducted after a medicine is authorized, evaluating long-term safety and real-world effectiveness.
Local Context (Ireland/EU): Often mandated by the EMA as part of post-authorization safety commitments.
PIL Regulatory Affairs
Package Leaflet.
Local Context (Ireland/EU): The leaflet included in the medicine box containing information for patients. It must align exactly with the approved SmPC in local languages.
PIP Regulatory Affairs
Paediatric Investigation Plan.
Local Context (Ireland/EU): A research and development plan to ensure that necessary data on the safety and efficacy of a medicine in children are gathered.
Placebo Clinical Trials
An inactive substance designed to look identical to the active investigational drug, used as a control in trials.
Local Context (Ireland/EU): Used to isolate the clinical effect of the active pharmaceutical ingredient.
Plasmid Biotechnology
A small, circular, double-stranded DNA molecule that is distinct from a cell's chromosomal DNA, commonly used as a vector in gene cloning.
Local Context (Ireland/EU): Quality control departments validate plasmids for purity and sequence identity before bioprocess scale-up.
PSUR Pharmacovigilance
Periodic Safety Update Report.
Local Context (Ireland/EU): A pharmacovigilance document providing an evaluation of the risk-benefit balance of a medicine, submitted at defined time points post-approval.
Public Relations Regulatory Affairs
The strategic practice of managing and disseminating information from an individual or organization to the public to construct a favorable reputation.
Local Context (Ireland/EU): For life science firms in Ireland, PR campaigns are regulated by HPRA codes to avoid off-label promotional violations.
Q
QA Quality Assurance
Quality Assurance.
Local Context (Ireland/EU): The wide-ranging concept covering all matters that individually or collectively influence the quality of a product, ensuring it is fit for its intended use.
QC Quality Assurance
Quality Control.
Local Context (Ireland/EU): The part of GMP concerned with sampling, specifications, and testing, ensuring that the necessary and relevant tests are actually carried out.
QP Quality Assurance
Qualified Person.
Local Context (Ireland/EU): A legally mandated role in the EU/EEA. The QP certifies that each batch of medicinal products has been manufactured in accordance with GMP and the marketing authorization.
QPPV Pharmacovigilance
Qualified Person Responsible for Pharmacovigilance.
Local Context (Ireland/EU): An EU-mandated executive responsible for the establishment and maintenance of the safety database and system for a marketing authorization holder.
Qualification Quality Assurance
The process of testing equipment, utilities, or systems to ensure they work correctly (divided into Installation, Operational, and Performance Qualification).
Local Context (Ireland/EU): Qualification (IQ/OQ/PQ) is the precursor to overall process validation.
R
REC Clinical Trials
Research Ethics Committee.
Local Context (Ireland/EU): The local or national board of experts reviewing trial protocols to protect the rights, safety, and well-being of trial subjects.
Recombinant DNA Biotechnology
DNA molecules formed by laboratory methods of genetic recombination to bring together genetic material from multiple sources.
Local Context (Ireland/EU): Used to engineer host cell lines (like CHO cells) for therapeutic protein synthesis.
RMP Pharmacovigilance
Risk Management Plan.
Local Context (Ireland/EU): A detailed description of the risk management system required in the EU for identifying and minimizing the safety risks of a medicine.
RP Quality Assurance
Responsible Person.
Local Context (Ireland/EU): The person designated at a pharmaceutical wholesale distribution site to ensure that GDP (Good Distribution Practice) requirements are met.
S
SAE Pharmacovigilance
Serious Adverse Event.
Local Context (Ireland/EU): An event resulting in death, life-threatening situation, hospitalization, persistent disability, or congenital anomaly.
Scientific Advice Regulatory Affairs
Formal meetings where developers discuss clinical, non-clinical, or quality testing plans with regulators before submitting marketing applications.
Local Context (Ireland/EU): HPRA offers Scientific Advice to Irish life science startups and academic research teams to streamline development.
Serialization Manufacturing
The process of printing unique 2D barcodes and serial numbers on medicine packages for trace-and-track validation.
Local Context (Ireland/EU): Mandated in the EU by the Falsified Medicines Directive (FMD) to secure the distribution supply chain.
Signal Detection Pharmacovigilance
The systematic search for new risks or safety changes by looking at adverse event database trends.
Local Context (Ireland/EU): EMA mandates ongoing signal detection using global healthcare registry databases.
Single-Use Technology Manufacturing
Disposable manufacturing equipment components (such as bags and connectors) used in place of traditional stainless steel.
Local Context (Ireland/EU): Reduces cross-contamination risks and cleaning validation requirements in biopharma facilities.
SIP Manufacturing
Sterilize-in-Place / Steam-in-Place.
Local Context (Ireland/EU): An automated thermal method of sterilizing process lines and bioreactors using saturated steam without disassembling the system.
SmPC Regulatory Affairs
Summary of Product Characteristics.
Local Context (Ireland/EU): The official document approved by regulators outlining how a medicine should be used safely, forming the basis for the Package Leaflet (PIL).
SOP Quality Assurance
Standard Operating Procedure.
Local Context (Ireland/EU): Step-by-step instructions compiled by an organization to help workers carry out complex routine operations safely and consistently.
T
Thought Leadership Regulatory Affairs
The practice of expressing authoritative, original ideas and commentary in a specialized field to establish expertise and credibility.
Local Context (Ireland/EU): Highly utilized by Quality Assurance and Regulatory directors on LinkedIn to build site and personal authority.
Transfection Biotechnology
The process of deliberately introducing nucleic acids into eukaryotic cells to alter their genetic makeup.
Local Context (Ireland/EU): Crucial step in developing host cell lines for recombinant biomanufacturing.
U
Upstream Processing Manufacturing
The initial stages of bioprocessing including cell line selection, media preparation, cell inoculation, and growth in bioreactors.
Local Context (Ireland/EU): Focuses on optimizing yields before cell harvest and purification.
V
Validation Quality Assurance
Documented evidence providing a high degree of assurance that a specific process, method, or system will consistently produce a product meeting specifications.
Local Context (Ireland/EU): Essential for all manufacturing equipment and analytical methods in Ireland.
Variations Regulatory Affairs
Changes made to the parameters of an approved marketing authorization after a medicine is on the market.
Local Context (Ireland/EU): Categorized into Type IA (minor, do not require approval), Type IB (minor, require validation), and Type II (major scientific assessment required).
W
WFI Manufacturing
Water for Injection.
Local Context (Ireland/EU): High-purity water used as an excipient or vehicle for parenterals. Under EU pharmacopoeia rules, WFI must meet strict microbial and chemical limits.